NESA XSIGNAL® recovery in athletics
NESA · Athletics

The line between training and overtraining.

Athletics — and especially middle- and long-distance running — is the sport in which the overtraining syndrome was first systematically described in sports medicine. We explain what today's science shows — with a precise source — and where NESA realistically fits.

Informational material · not medical advice
History of sports medicine

Athletics wrote the first chapter of overtraining research.

Decades before wearable HRV devices

Disciplines in which the topic is particularly well researched
✓marathon and road running
✓middle-distance running (800–1500 m)
✓long-distance running (5000–10,000 m)
✓race walking
The classic “staleness” literature

Decades ago, coaches and sports physicians already described so-called “staleness” in competitive runners — an unexplained decline in performance despite maintained or increased load. It was on this foundation that sports medicine later built the modern understanding of the overtraining syndrome — years before wearable HRV devices existed.

Historical context, not a diagnostic criterion.

Consensus position · sports medicine

The joint consensus of the ECSS and ACSM remains the leading authoritative document on the topic.

Joint consensus · 2013

The overtraining syndrome is a “prolonged maladaptation”, not ordinary fatigue.

A multidisciplinary expert group of the European College of Sport Science (ECSS) and the American College of Sports Medicine (ACSM) defines the overtraining syndrome (OTS) as a prolonged maladaptation to training load that disrupts the body's hormonal, biological and neurological regulatory mechanisms — with accompanying mood disturbances and a decline in sports performance.

The autonomic nervous system occupies a central place in this picture: the classic description of OTS includes a disturbed balance between the sympathetic and parasympathetic branches. In research built on this consensus framework, heart-rate variability (HRV) has become established as a sensitive, non-invasive early indicator of autonomic maladaptation — but the consensus position, confirmed by later reviews devoted specifically to HRV, is clear: HRV is a sensitive early signal, not a stand-alone diagnostic tool. It must be interpreted together with subjective wellness scales and performance data, not in isolation.

Source: Meeusen R, Duclos M, Foster C, Fry A, Gleeson M, Nieman D, Raglin J, Rietjens G, Steinacker J, Urhausen A (2013). “Prevention, diagnosis, and treatment of the overtraining syndrome: Joint consensus statement of the European College of Sport Science and the American College of Sports Medicine.” Medicine and Science in Sports and Exercise, 45(1):186–205. DOI: 10.1249/MSS.0b013e318279a10a.

Where NESA fits

Directed at the same autonomic system that overtraining throws out of balance.

NESA XSIGNAL® works with controlled microcurrents through the limbs, directed at the balance between the sympathetic and parasympathetic nervous system. This is exactly the system that the ECSS/ACSM consensus describes as disturbed in the overtraining syndrome — the thematic link is real.

The overtraining syndrome is a real clinical condition and remains in the hands of the sports physician. Recovery and adaptation are the work of the athlete's own nervous system — NESA supports the conditions in which it regains its rhythm, and gives the physician a measurable marker (HRV) for follow-up.

The general overview of NESA in sports medicine is available on the Sports medicine page.

Documented NESA results

In basketball players, and in sleep and HRV studies, NESA already has measured results — and we have every reason to expect them to apply to runners and athletes as well.

In professional basketball players in a randomised placebo-controlled trial (FC Barcelona, García et al., Frontiers in Physiology 2022) the NESA group showed a significantly lower nocturnal heart rate and less wakefulness during the night. In sleep studies, +20% REM phase and +32 minutes of total sleep duration were measured (Medina-Ramírez, Stresses 2024), as well as −11% nocturnal heart rate (García et al., Front Physiol 2022). In a pilot randomised trial, heart-rate variability (SDNN) improved significantly more with NESA (Melián-Ortíz et al., Brain Sciences 2025).

The common denominator is autonomic balance — exactly the system that the ECSS/ACSM consensus places at the centre of overtraining. That is why, in athletes under medical supervision, we start with HRV before and after the protocol.

Limits and safety

NESA supports autonomic regulation — hand in hand with sports-medical assessment.

·

The overtraining syndrome is diagnosed and followed up by a sports physician — there, HRV, the training diary and clinical judgement work together.

·

In an athlete under medical supervision, NESA can be the part that supports autonomic balance — while the nervous system itself restores its rhythm.

·

Absolute contraindications: pacemaker and other active electrical implants, pregnancy, epilepsy — checked against the device IFU before every application.

For coaches and sports physicians

If you are considering NESA as an additional element in the care of an athlete with signs of overtraining — treat this page as a starting point for a conversation. Diagnosis and the treatment plan remain entirely in the hands of the sports-medicine team.

Related field

The full overview of NESA in sports medicine.

Sports medicine

Mechanism, protocols, documented results and applications of NESA in sport.

→
NO-OBLIGATION CONVERSATION

Discuss the specific case with us.

For sports physicians, physiologists and coaches: we explain the mechanism of NESA, the available protocols and how to judge whether it is a suitable tool within the athlete's overall plan.

Request a conversation →
NESA · Materials

NESA information pack

Enter your e-mail, confirm with one click — and the NESA presentations (BG · DE · EN) arrive automatically. Free, no spam.

Request materials ↓